OR WAIT null SECS
April 25, 2023
The leaked study summary found that Carvykti (ciltacabtagene autoleucel) reduced disease progression by 74%.
April 21, 2023
A report from Business Standard highlighted India’s recent growth in the pharma sector.
April 20, 2023
GSK has reached an agreement to acquire late-stage biopharmaceutical company BELLUS Health.
April 18, 2023
Merck will acquire Prometheus Biosciences, a clinical-stage biotechnology company specializing in immune-mediated diseases, at a total equity valuation of $10.8 billion.
April 14, 2023
FDA has granted fast track designation to Caribou Biosciences for its allogeneic CAR-T cell therapy for relapsed or refractory multiple myeloma.
Under this partnership, the two companies will develop bioprinted tissue therapeutics for diabetes and obesity.
Ginkgo Bioworks has acquired StrideBio's AAV capsid discovery and engineering platform and has formed a partnership with WARF for development of next-gen cell therapies.
The acquisition of Cell Systems will bolster AnaBios’ portfolio of human tissue and cells for use in drug discovery.
April 10, 2023
Will court challenges to FDA’s oversight authority open the door for multiple lawsuits to block agency decisions on all sides?
April 07, 2023
If approved, Johnson & Johnson would pay $8.9 billion to resolve all current and future claims in its ongoing talc litigation.